Click to learn about APOLLOE4

Phase 3 study evaluated efficacy of valiltramiprosate in APOE4/4 Early AD subjects

APOE4/4 homozygous

Valiltramiprosate Phase 3 trial in APOE4/4 patients with Early AD

APOLLOE4 pivotal trial enrolled 325 subjects

ALZ-801 Alzheimer's medicine

Valiltramiprosate development history

Valiltramiprosate Development History

*Active metabolite of valiltramiprosate, licensed by Alzheon from Bellus Health/Neurochem in 2013; Orange relates to study start date